U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858292) titled 'VICIA FABA PEPTIDES AND RESISTANCE TRAINING IN THE ELDERLY' on Sept. 29.
Brief Summary: This randomized, double-blind, placebo-controlled clinical trial aims to investigate the effects of supplementation with peptides derived from Vicia faba L. combined with supervised resistance training in physically active and inactive older adults.
Approximately 100 adults aged 60 years or older will be enrolled. Participants will first be classified as physically active or inactive according to their habitual physical activity level and will then be randomly assigned to receive either Vicia faba L.-derived peptides (2.5 g/day) or placebo. All p...